Alvotech (ALVO)
13.49
-0.01
(-0.07%)
USD |
NASDAQ |
May 17, 16:00
13.49
0.00 (0.00%)
After-Hours: 20:00
Alvotech Cash from Operations (Quarterly): -67.16M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -67.16M |
| September 30, 2023 | -117.02M |
| June 30, 2023 | -41.87M |
| March 31, 2023 | -86.13M |
| Date | Value |
|---|---|
| December 31, 2022 | -64.38M |
| September 30, 2022 | -106.86M |
| June 30, 2022 | -103.57M |
| March 31, 2022 | -37.58M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-117.02M
Minimum
Sep 2023
-37.58M
Maximum
Mar 2022
-78.07M
Average
-76.65M
Median
Cash from Operations (Quarterly) Benchmarks
| AbbVie Inc | 4.04B |
| Teva Pharmaceutical Industries Ltd | -124.00M |
| Moolec Science SA | -3.904M |
| Procaps Group SA | 47.39M |
| NeuroMetrix Inc | -1.450M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -10.46M |
| Cash from Financing (Quarterly) | 20.66M |
| Free Cash Flow | -358.66M |
| Free Cash Flow Per Share (Quarterly) | -0.2909 |
| Free Cash Flow to Equity (Quarterly) | -125.71M |
| Free Cash Flow to Firm (Quarterly) | -16.23M |
| Free Cash Flow Yield | -11.20% |